Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · Real-Time Price · USD
34.78
-1.73 (-4.74%)
Nov 20, 2025, 2:19 PM EST - Market open
Structure Therapeutics Market Cap
Structure Therapeutics has a market cap or net worth of $2.11 billion as of November 20, 2025. Its market cap has decreased by -7.15% in one year.
Market Cap
2.11B
Enterprise Value
1.42B
1-Year Change
-7.15%
Ranking
Category
Stock Price
$34.78
Market Cap Chart
Since the IPO on February 3, 2023, Structure Therapeutics's market cap has increased from $548.82M to $2.11B, an increase of 284.53%. That is a compound annual growth rate of 61.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2025 | 2.22B | 42.66% |
| Dec 31, 2024 | 1.55B | -22.02% |
| Dec 29, 2023 | 1.99B | 262.83% |
| Feb 3, 2023 | 548.82M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 914.81B |
| Johnson & Johnson | 480.85B |
| AbbVie | 413.57B |
| UnitedHealth Group | 290.34B |
| AstraZeneca | 277.65B |
| Novartis AG | 255.14B |
| Merck & Co. | 230.48B |
| Abbott Laboratories | 226.11B |